Literature DB >> 16758120

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer.

R Asola1, H Huhtala, K Holli.   

Abstract

The aim of this study was to assess the intensity of diagnostic testing and cancer treatment of 335 women with advanced breast cancer during their last 6 months before death between 1995 and 1998 in the Pirkanmaa and Satakunta health care districts and to compare it to the practice in earlier decades, the 1970s and 1980s. Data for 1990s material were collected from medical records in 30-day periods starting from the patient's death backwards. In this material 46.9% of all laboratory tests and 40% of radiological tests during the last 6 months of life were made during the last 2 months prior to death. In the last month 63.9% of patients continued on endocrine therapy and 19.7% on chemotherapy. Patient symptoms and deterioration in general condition showed the appropriate point to discontinue cancer-related treatment and concentrate on palliation of symptoms to be about 2 months prior to death. Resources devoted to diagnostic investigations and treatment of cancer in terminally ill patients could be better used for their care. This would be more likely to improve patients' quality of life and save resources.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758120     DOI: 10.1007/s10549-006-9224-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Specific anticancer treatments in the last 3 months of life: a French experience.

Authors:  Erika Viel; Loïc Chaigneau; Eleonor Fanton; Elsa Kalbacher; Antoine Thiery-Vuillemnin; Cristian Villanueva; Erion Dobi; Elsa Curtit; Hamadi Almotlak; Régis Aubry; Xavier Pivot
Journal:  Support Care Cancer       Date:  2012-06-27       Impact factor: 3.603

2.  Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?

Authors:  Gianmauro Numico; Antonio Trogu; Antonella Cristofano; Alessandro Mozzicafreddo; Giulia Courthod; Pierfrancesco Franco; Nicola Silvestris
Journal:  Support Care Cancer       Date:  2014-05-11       Impact factor: 3.603

3.  Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer.

Authors:  Aju Mathew; Tala Achkar; Shira Abberbock; Gurprataap S Sandhu; Mini Elizabeth Jacob; Vipin Das Villgran; Margaret Q Rosenzweig; Shannon Puhalla; Adam M Brufsky
Journal:  Breast J       Date:  2017-08-28       Impact factor: 2.431

4.  Prospective analysis of 30-day mortality following palliative chemotherapy at a tertiary cancer centre.

Authors:  James A McCracken; Adrian Dabscheck; Maria Coperchini; Ilana Hornung; Azim Jalali; Georgina Akers; Amalia Karahalios; Fran Gore; Lara Lipton
Journal:  Cancer Rep (Hoboken)       Date:  2018-09-27

5.  The sensory and coping intervention for women newly diagnosed with metastatic breast cancer.

Authors:  Margaret Rosenzweig; Heidi Donovan; Kathleen Slavish
Journal:  J Cancer Educ       Date:  2010-09       Impact factor: 2.037

6.  Validation of prognostic scores for survival in cancer patients beyond first-line therapy.

Authors:  Olivier Trédan; Isabelle Ray-Coquard; Gisèle Chvetzoff; Paul Rebattu; Agathe Bajard; Sylvie Chabaud; David Pérol; Chadi Saba; Florent Quiblier; Jean-Yves Blay; Thomas Bachelot
Journal:  BMC Cancer       Date:  2011-03-15       Impact factor: 4.430

Review 7.  Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review.

Authors:  Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton
Journal:  J Pain Symptom Manage       Date:  2019-10-19       Impact factor: 3.612

8.  Population-based study on use of chemotherapy in men with castration resistant prostate cancer.

Authors:  Ingela Franck Lissbrant; Hans Garmo; Anders Widmark; Pär Stattin
Journal:  Acta Oncol       Date:  2013-02-21       Impact factor: 4.089

9.  Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers.

Authors:  Justus Tönnies; Mechthild Hartmann; Dirk Jäger; Caroline Bleyel; Nikolaus Becker; Hans-Christoph Friederich; Markus W Haun
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.